TEVA PHARMACEUTICAL INDUSTRIES LIMITED Goodwill
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Goodwill of $15.84 billion as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2026-07-29
- 2026-06-30: Goodwill $15.84B.
- 2026-03-31: Goodwill $15.82B.
- 2025-12-31: Goodwill $16.00B.
- 2025-09-30: Goodwill $15.95B.
| Period end | Goodwill | Goodwill as first filed |
|---|---|---|
| 2026-06-30 | $15.84B 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $15.82B 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $16.00B 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $15.95B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $15.95B 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $15.48B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $16.00B 10-Q · filed 2026-07-29 | $15.15B 10-K · filed 2025-02-05 |
| 2024-09-30 | $16.12B 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $16.49B 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $17.01B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $17.18B 10-K · filed 2026-02-03 | |
| 2023-09-30 | $16.89B 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $17.12B 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $17.80B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $17.18B 10-K · filed 2026-02-03 | $17.63B 10-K · filed 2023-02-10 |
| 2022-09-30 | $18.43B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $18.84B 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $19.99B 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $17.63B 10-K · filed 2025-02-05 | $20.04B 10-K · filed 2022-02-09 |
| 2021-09-30 | $20.18B 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $20.42B 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $20.30B 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $20.62B 10-K · filed 2023-02-10 | |
| 2020-09-30 | $20.23B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $24.62B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $24.49B 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $24.85B 10-K · filed 2022-02-09 | |
| 2019-09-30 | $24.66B 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $24.91B 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $24.82B 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $24.92B 10-K · filed 2021-02-10 | |
| 2018-09-30 | $27.59B 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $27.65B 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $28.46B 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $28.41B 10-K · filed 2020-02-21 | |
| 2017-09-30 | $39.39B 6-K · filed 2017-11-02 | |
| 2017-06-30 | $40.03B 6-K · filed 2017-08-03 | |
| 2017-03-31 | $45.03B 6-K · filed 2017-05-11 | |
| 2016-12-31 | $44.41B 10-K · filed 2019-02-19 | |
| 2016-09-30 | $40.30B 6-K · filed 2016-11-15 | |
| 2016-06-30 | $20.70B 6-K · filed 2016-08-04 | |
| 2016-03-31 | $20.27B 6-K · filed 2016-05-09 | |
| 2015-12-31 | $19.02B 10-K · filed 2018-02-12 | |
| 2015-09-30 | $19.17B 6-K · filed 2015-10-29 | |
| 2015-06-30 | $19.26B 6-K · filed 2015-07-30 | |
| 2015-03-31 | $17.94B 6-K · filed 2015-04-30 | |
| 2014-12-31 | $18.41B 20-F · filed 2017-02-15 | |
| 2014-09-30 | $18.72B 6-K · filed 2014-10-30 | |
| 2014-06-30 | $18.95B 6-K · filed 2014-07-31 | |
| 2014-03-31 | $18.98B 6-K · filed 2014-05-02 | |
| 2013-12-31 | $18.98B 20-F · filed 2016-02-11 | |
| 2013-09-30 | $18.91B 6-K · filed 2013-10-31 | |
| 2013-06-30 | $18.59B 6-K · filed 2013-08-01 | |
| 2013-03-31 | $18.65B 6-K · filed 2013-05-02 | |
| 2012-12-31 | $18.86B 20-F · filed 2014-02-10 | |
| 2012-09-30 | $18.66B 6-K · filed 2012-11-01 | |
| 2012-06-30 | $18.37B 6-K · filed 2012-08-02 | |
| 2012-03-31 | $18.71B 6-K · filed 2012-05-09 | |
| 2011-12-31 | $18.29B 20-F · filed 2014-02-10 | |
| 2011-09-30 | $15.79B 6-K · filed 2011-11-02 | |
| 2011-06-30 | $15.93B 6-K · filed 2011-07-28 | |
| 2011-03-31 | $15.80B 6-K · filed 2011-05-11 | |
| 2010-12-31 | $15.23B 20-F · filed 2013-02-12 | |
| 2010-09-30 | $15.57B 6-K · filed 2010-11-02 | |
| 2010-06-30 | $12.22B 6-K · filed 2010-07-27 | |
| 2010-03-31 | $12.56B 6-K · filed 2010-05-04 | |
| 2009-12-31 | $12.67B 20-F · filed 2012-02-17 | |
| 2009-09-30 | $12.72B 6-K · filed 2009-11-03 | |
| 2009-06-30 | $12.22B 6-K · filed 2009-07-29 | |
| 2009-03-31 | $12.31B 6-K · filed 2009-05-07 | |
| 2008-12-31 | $12.30B 20-F · filed 2011-02-15 |